The implication of dendritic cells in lung diseases: Immunological role of toll-like receptor 4
Authors:
- Shurui XuanSXShurui Xuan
- Yuan MaYMYuan Ma
- Honglei ZhouHZHonglei Zhou
- Shengwei GuSGShengwei Gu
- Xin YaoXYXin Yao
- Xiaoning ZengXZXiaoning Zeng
Open Access
- 1 November 2024
- journal article
- research article
- Published by KEAI Publishing in Genes & Diseases
- Vol. 11 (6) , 101007
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 166 references indexed in Scilit:
- The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke‐induced inflammation in chronic obstructive pulmonary diseaseImmunity, Inflammation and Disease, 2022
- Interplay between alveolar epithelial and dendritic cells and Mycobacterium tuberculosisJournal of Leukocyte Biology, 2020
- The immunostimulatory effects and pro‐apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll‐like receptor 4Cancer Medicine, 2019
- Extracellular CIRP (eCIRP) and inflammationJournal of Leukocyte Biology, 2019
- Mycobacterium tuberculosis RpfE promotes simultaneous Th1‐ and Th17‐type T‐cell immunity via TLR4‐dependent maturation of dendritic cellsEuropean Journal of Immunology, 2015
- Vaccine molecules targeting Xcr1 on cross‐presenting DCs induce protective CD8+ T‐cell responses against influenza virusEuropean Journal of Immunology, 2014
- MyD88 and TRIF synergistic interaction is required for TH1‐cell polarization with a synthetic TLR4 agonist adjuvantEuropean Journal of Immunology, 2013
- Tumor microenvironment is multifacetedCancer and Metastasis Reviews, 2011
- Klebsiella pneumoniae‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cellsEuropean Journal of Immunology, 2010
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapyCancer Immunology, Immunotherapy, 2010